Copyright 2001 eMediaMillWorks, Inc.
(f/k/a Federal
Document Clearing House, Inc.)
Federal Document Clearing House
Congressional Testimony
April 24, 2001, Tuesday
SECTION: CAPITOL HILL HEARING TESTIMONY
LENGTH: 1120 words
COMMITTEE:
SENATE FINANCE
HEADLINE: TESTIMONY
PRESCRIPTION DRUG COVERAGE
TESTIMONY-BY: CHARLES
GRASSLEY , SENATOR
AFFILIATION: IOWA
BODY: April 24, 2001 U.S. SENATE COMMITTEE ON
Finance SENATOR CHUCK GRASSLEY, OF IOWA - CHAIRMAN Hearing, "Finding the Right
Fit:
Medicare, Prescription Drugs and Current Coverage Options"
Today, the Finance Committee looks again at one of the year's biggest issues:
Medicare reform and prescription drugs. In March, we heard testimony from a
number of expert witnesses, including the Congressional Budget Office and the
General Accounting Office regarding the potential cost of a Medicare drug
benefit. This morning, we move forward to discuss the implications a new
Medicare drug benefit may have on prescription drug options already available to
older Americans. Although Medicare does not provide a complete prescription drug
benefit, it is incorrect to assume that the Medicare population is completely
without any coverage. In fact, in 1998 73 percent of Medicare beneficiaries had
prescription drug coverage for some portion of the year. While some coverage may
be limited, other coverage is much more comprehensive. I've heard from Iowans on
both sides of the coin; some need additional assistance for prescription drug
costs. However, many others are terrified at the prospect of losing their
current coverage as a result of a new federally-mandated benefit. Today, the
most common source of prescription drug coverage for the Medicare population is
through employer-sponsored health plans for retirees. In fact, of all Medicare
beneficiaries that have drug coverage, close to 45 percent have such coverage
through employer-sponsored retiree plans. Through these retiree plans,
beneficiaries pay as little as $5 for generic drugs, $ 1 0 to $14 for brand-name
pharmaceuticals, experience modest deductibles, and generally have no limit on
annual drug expenditures. It is easy to understand, then, why older Americans
want to maintain this kind of coverage, and it is important for Congress to
consider these facts as we craft Medicare legislation. In addition to retiree
health plan options, nearly 6 million Medicare beneficiaries receive
prescription drug benefits through Medicare+Choice plans. Under these plans,
beneficiaries enjoy the benefits of a coordinated approach to wellness and
treatment. Benefits such as disease management, step therapy, and home delivery
are just a few of the additional pharmaceutical benefits available through a
managed care approach. Still other beneficiaries access prescription drug
benefits through "Medigap" plans, Medicaid programs, and State Pharmacy
Assistance Programs. In light of these issues, Congress would be foolhardy to
ignore coverage options now available to Medicare beneficiaries. There is no
doubt a benefit guided by the federal government will impact current programs.
However, the extent to which a new drug benefit can complement rather than
supplant current coverage will result in a wiser use of taxpayer dollars and
equally important, assurance that older Americans can keep the existing drug
benefits they really like. This morning we will hear from a panel of expert
witnesses who will provide valuable information about the prescription drug
Options currently available to the Medicare population. In addition to learning
more about these current options, I look forward to deepening my understanding
of the lessons being learned by states, Medicare risk plans, and employers in
serving the diverse characteristics of the Medicare population. Their wisdom can
be helpful to us as we consider how best to meet the needs of beneficiaries. It
is my hope that today's testimony will aid the Senate in creating a
fiscally-responsible, common-sense Medicare drug benefit that includes much
needed reforms to the program. I look forward to continuing to work on this
critical issue with the assistance of each member of the committee.
LOAD-DATE: April 25, 2001, Wednesday